Home
About Us
Cognition
Pipeline
News
Talent
Contact
中
Industry Trends
Technological Frontier
Information of YuanVore
Location：
Home
>
News
>
Industry Trends
Current status and future directions of clinical use of iPS cells - with a focus on Japan
09
2024-01
2024-01-09
The National stem cell resource Bank continues to share cell resources
05
2024-01
2024-01-05
Progress of stem cell drug registration and application in China (December 2023)
04
2024-01
2024-01-04
New advances in stem cells: Japan has included stem cells in its medical insurance
29
2023-12
2023-12-29
Illustration: Supercells - Induced pluripotent stem Cells (IPscs)
28
2023-12
2023-12-28
More than 700 million domestic enterprises introduced iPSC derivative therapy new developments! Can be directly induced, mass production
26
2023-12
2023-12-26
In 2023, China completed the first stem cell-derived islet cells to treat diabetes! Take stock of the 4 key pathways of cell therapy for diabetes.
25
2023-12
2023-12-25
Stem cells exert "living bandage" properties, or will reverse the difficult treatment of venous ulcers in lower limbs
21
2023-12
2023-12-21
Prev
...
21
22
23
24
25
...
Next
